174 related articles for article (PubMed ID: 29429058)
1. Immunosuppressive monocytes (CD14
Lima DS; Lemes RPG; Matos DM
Med Oncol; 2018 Feb; 35(3):36. PubMed ID: 29429058
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.
Lin Y; Gustafson MP; Bulur PA; Gastineau DA; Witzig TE; Dietz AB
Blood; 2011 Jan; 117(3):872-81. PubMed ID: 21063024
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.
Vuk-Pavlović S; Bulur PA; Lin Y; Qin R; Szumlanski CL; Zhao X; Dietz AB
Prostate; 2010 Mar; 70(4):443-55. PubMed ID: 19902470
[TBL] [Abstract][Full Text] [Related]
4. [T-lymphocyte and monocyte activation in the course of infection in children with neoplastic disease].
Luczynsk W; Stasiak-Barmuta A; Muszynska-Roslan K; Kasprzycka E
Med Wieku Rozwoj; 2002; 6(1):31-41. PubMed ID: 12177511
[TBL] [Abstract][Full Text] [Related]
5. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.
Xiu B; Lin Y; Grote DM; Ziesmer SC; Gustafson MP; Maas ML; Zhang Z; Dietz AB; Porrata LF; Novak AJ; Liang AB; Yang ZZ; Ansell SM
Blood Cancer J; 2015 Jul; 5(7):e328. PubMed ID: 26230952
[TBL] [Abstract][Full Text] [Related]
6. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function.
Du J; Sun X; Song Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815
[TBL] [Abstract][Full Text] [Related]
7. CD14(+) HLA-DR low/(-) monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma.
Khalifa KA; Badawy HM; Radwan WM; Shehata MA; Bassuoni MA
Int J Lab Hematol; 2014 Dec; 36(6):650-5. PubMed ID: 24636145
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
[TBL] [Abstract][Full Text] [Related]
9. [Changes of Peripheral Blood Marrow-Derived Suppressor Cell Level after Chemotherapy Induction Remission by VDLP Regimen and Their Relationship with Immune System in B-ALL Children].
Guo XM; Fang YJ; Lv CL; Wang YR; Sun XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1611-1614. PubMed ID: 29262884
[TBL] [Abstract][Full Text] [Related]
10. The CD14
Mengos AE; Gastineau DA; Gustafson MP
Front Immunol; 2019; 10():1147. PubMed ID: 31191529
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
[TBL] [Abstract][Full Text] [Related]
12. Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: profile comparison.
Brusa D; Simone M; Gontero P; Spadi R; Racca P; Micari J; Degiuli M; Carletto S; Tizzani A; Matera L
Int J Urol; 2013 Oct; 20(10):971-8. PubMed ID: 23421558
[TBL] [Abstract][Full Text] [Related]
13. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
[No Abstract] [Full Text] [Related]
14. Dendritic cell depletion in burn patients is regulated by MafB expression.
Williams KN; Szilagyi A; He LK; Conrad P; Halerz M; Gamelli RL; Shankar R; Muthumalaiappan K
J Burn Care Res; 2012; 33(6):747-58. PubMed ID: 22868453
[TBL] [Abstract][Full Text] [Related]
15. Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.
Witkowski MT; Dolgalev I; Evensen NA; Ma C; Chambers T; Roberts KG; Sreeram S; Dai Y; Tikhonova AN; Lasry A; Qu C; Pei D; Cheng C; Robbins GA; Pierro J; Selvaraj S; Mezzano V; Daves M; Lupo PJ; Scheurer ME; Loomis CA; Mullighan CG; Chen W; Rabin KR; Tsirigos A; Carroll WL; Aifantis I
Cancer Cell; 2020 Jun; 37(6):867-882.e12. PubMed ID: 32470390
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14(pos)CD163(high)HLA-DR(low))following cardiopulmonary bypass.
Quimby KR; Greenidge A; Harris A; Landis RC
Cytometry B Clin Cytom; 2010 Sep; 78(5):357-60. PubMed ID: 20533393
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
[TBL] [Abstract][Full Text] [Related]
18. Elevated markers of inflammation and endothelial activation and increased counts of intermediate monocytes in adult survivors of childhood acute lymphoblastic leukemia.
Sulicka J; Surdacki A; Mikołajczyk T; Strach M; Gryglewska B; Ćwiklińska M; Balwierz W; Guzik T; Grodzicki TK
Immunobiology; 2013 May; 218(5):810-6. PubMed ID: 23182707
[TBL] [Abstract][Full Text] [Related]
19. The CD14+CD16+ monocytes in erysipelas are expanded and show reduced cytokine production.
Horelt A; Belge KU; Steppich B; Prinz J; Ziegler-Heitbrock L
Eur J Immunol; 2002 May; 32(5):1319-27. PubMed ID: 11981819
[TBL] [Abstract][Full Text] [Related]
20. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]